Validity of mouse models for the study of tissue transglutaminase in neurodegenerative diseases
- 31 March 2004
- journal article
- research article
- Published by Elsevier in Molecular and Cellular Neuroscience
- Vol. 25 (3) , 493-503
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Transglutaminases: crosslinking enzymes with pleiotropic functionsNature Reviews Molecular Cell Biology, 2003
- Up‐regulation of tissue‐type transglutaminase after traumatic brain injuryJournal of Neurochemistry, 2002
- Huntington's disease: new hope for therapeuticsTrends in Neurosciences, 2001
- Intron-Exon Swapping of Transglutaminase mRNA and Neuronal Tau Aggregation in Alzheimer's DiseaseJournal of Biological Chemistry, 2001
- Apoptosis-linked in vivo regulation of the tissue transglutaminase gene promoterCell Death & Differentiation, 2000
- The promoter of the mouse tissue transglutaminase gene directs tissue-specific, retinoid-regulated and apoptosis-linked expressionCell Death & Differentiation, 1997
- Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in BrainScience, 1997
- Polyglutamine Domains Are Substrates of Tissue Transglutaminase: Does Transglutaminase Play a Role in Expanded CAG/Poly‐Q Neurodegenerative Diseases?Journal of Neurochemistry, 1997
- Hepatocyte Growth Factor Induces Transglutaminase Activity That Negatively Regulates the Growth Signal in Primary Cultured HepatocytesExperimental Cell Research, 1996
- Phenotype-specific “tissue” transglutaminase regulation in human neuroblastoma cells in response to retinoic acid: Correlation with cell death by apoptosisInternational Journal of Cancer, 1992